Following a public consultation period (until October 15, 2025), the Algerian Ministry of Health, Ministry of Pharmaceutical Industry, the National Pharmacovigilance and Materiovigilance Centre (CNPM), and the National Agency for Pharmaceutical Products (ANPP) have jointly issued the final Algerian Guide to Good Pharmacovigilance Practices (BPPV) – Version 2.0, December 2025.
This document details the safety signals reviewed and the regulatory actions recommended by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) during its meeting in November 2025.
On January 5, 2026, the landscape of weight management in America shifted with the broad availability of Novo Nordisk's Wegovy® (semaglutide) pill. As the first and only FDA-approved oral GLP-1 receptor agonist for chronic weight management, it represents a monumental shift from injectable therapy, promising to expand access and transform patient experience. However, with...
A new international study protocol, published by the World Health Organization (WHO) in 2025, lays the groundwork for a critical public health initiative: determining how often a rare blood disorder occurs in children across low- and middle-income countries (LMICs). The study focuses on thrombocytopenia—a condition characterized by abnormally low platelet counts that can lead...
In a significant regulatory decision, the U.S. Food and Drug Administration (FDA) has approved an update to the label for the long-acting contraceptive Depo-Provera (medroxyprogesterone acetate). The change, finalized in December 2025, adds a formal warning about a potential increased risk of developing meningioma, a type of brain tumor. This action follows emerging scientific evidence...
This study investigated why reports of side effects (adverse drug reactions or ADRs) from a common HIV medication in Uganda are often incomplete, which hinders effective drug safety monitoring.
Hemodialysis vascular access is often termed the “lifeline” of patients with end-stage renal disease. However, due to frequent complications, it is also considered the “Achilles heel” of hemodialysis therapy. While traditional patient safety efforts have focused on clinician training and patient education, this chapter advocates for a transformative approach—one that prioritizes individualization of care and active...
Advancing Medication Safety Through Knowledge and Vigilance
